Immunogenetic Mechanisms of Vaccine Response
Immunogenetic Mechanisms of Vaccine Response
批准号:
7771700
负责人:
Gregory A. Poland
金额:
$38.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-02-01 至 2011-02-28
关键词:
AllelesAnthrax diseaseCSF2RA geneCSF2RB geneCellsCellular ImmunityCytokine GeneCytokine Receptor GeneCytokine ReceptorsDataDevelopmentEpitopesFamilyFundingGenesGeneticGenetic PolymorphismGoalsGrantGranulocyte-Macrophage Colony-Stimulating FactorHIVHaplotypesHealthHepatitis CHumanHuman PapillomavirusIFNAR1 geneIFNAR2 geneIFNGR1 geneIFNGR2 geneIL12A geneIL12B geneImmuneImmune Response GenesImmune responseImmunityImmunizationImmunogeneticsIndividualInterferon-alphaInterleukin-10Interleukin-2Interleukin-4Interleukin-5Interleukin-6KnowledgeLifeLiteratureMeaslesMeasuresMediatingModelingOutcomePopulation HeterogeneityProteinsPublic HealthPublicationsPublishingReceptor GeneRoleRubellaRubella virus vaccineSamplingSmallpox VaccineTNFRSF1A geneTNFRSF1B geneTestingUnited States National Institutes of HealthVaccinationVaccinesValidationVariantViralViral VaccinesVirus DiseasesWorkarmcell mediated immune responsecohortcytokinedesigngene interactionhuman leukocyte antigen genehuman subjectinnovationneutralizing antibodynext generationnovel vaccinespopulation basedprogramsreceptorresponserubella antibodies
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This application is for renewed funding for years 6-10 of R01 AI48793. Our long-term objective isto
determine the genetic mechanisms influencing the immune response to live viral vaccines, and to answer the
question of how and to what degree differences in immune responses that depend upon the immunogenetics
of the individual determine the outcome of immunization with live viral vaccines. Because of the central role
of cytokines as intercellular protein messengers, and their receptors, in the immune response cascade, the
role of cytokine and cytokine receptor gene polymorphisms will be a primary focus of this
application, and we will focus on the influence of these polymorphisms on measures of humoral and cellular
immune response to a live viral vaccine - rubella - asa model with which to explore the influenceof
immunogenetics on the variability of vaccine response. To accomplish these goals, we propose thefollowing
specific aims: 1) To test_the hypothesis that significant associations exist between polymorphisms of specific
cytokine genes (IFNa, (3, y, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12A, IL-12B, TNFa and GM-CSF) and rubella
immune responses (neutralizing antibody level and markers of cell-mediated immunity), 2) To test the
hypothesis that significant associations exist between polymorphisms of specific cytokine receptor genes
(IL-2RA, IL-2RB, IL-2RG, IL-4R, IL-6R, IL-6ST, IL-10RA, IL-10RB, IL-12RB1, IL-12RB2, IFNAR1, IFNAR2,
IFNGR1, IFNGR2, TNFRSF1A, TNFRSF1B, CSF2RA and CSF2RB), and rubella immune responses, 3) To
test the hypothesis that significant associations exist between secreted cytokine protein levels (IFNa, (3, y,
IL-2, IL-4, IL-5, IL-6, IL-10, IL-12(p35 and p40), TNFa and GM-CSF) after ex vivo rubella stimulation and
rubella immune responses, and 4) To verify the associations between class I and II HLA genes and rubella
immune responses found in our previous study and to assess potential effects of gene-gene interactions on
these immune responses within a new validation cohort. The proposal is innovative as it examines the effect
of immunogenetics on variability of vaccine response. The significance of this information is that it will
provide a framework for estimating the contribution of HLA variability on variability of immune responses as
well as provide knowledge important to the development of new viral vaccines (HIV, HPV, Hepatitis C, and
others) in a genetically heterogeneous population.
Relevance to Public Health: This grant proposes to study the genes that influence and determine the
human immune response to rubella vaccine. The knowledge gained from these studies will enable us to
design new strategies and new vaccines to protect human health against viral diseases.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sample sizes and negative studies in clinical vaccine research.
临床疫苗研究中的样本量和阴性研究。
DOI:
10.1016/j.vaccine.2005.01.029
发表时间:
2005
期刊:
Vaccine
影响因子:
5.5
作者:
[Jacobson,RobertM, Poland,GregoryA]
通讯作者:
Poland,GregoryA
DOI:
10.1186/1471-2172-11-48
发表时间:
2010-10-05
期刊:
BMC immunology
影响因子:
3
作者:
[Pankratz VS, Vierkant RA, O'Byrne MM, Ovsyannikova IG, Poland GA]
通讯作者:
Poland GA
DOI:
10.1371/journal.pone.0099997
发表时间:
2014
期刊:
PloS one
影响因子:
3.7
作者:
[Haralambieva IH, Lambert ND, Ovsyannikova IG, Kennedy RB, Larrabee BR, Pankratz VS, Poland GA]
通讯作者:
Poland GA
Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA.
通过 IL-4 受体阻断 ELISA 测量麻疹病毒和麻疹衍生肽诱导的 IL-4。
DOI:
10.1016/j.jim.2004.02.002
发表时间:
2004
期刊:
Journal of immunological methods
影响因子:
2.2
作者:
[Dhiman,Neelam, Ovsyannikova,InnaG, Howe,RawleighC, Ryan,JennaE, Jacobson,RobertM, Poland,GregoryA]
通讯作者:
Poland,GregoryA
DOI:
10.1097/fpc.0b013e32834df186
发表时间:
2012-01
期刊:
Pharmacogenetics and genomics
影响因子:
2.6
作者:
[Ovsyannikova IG, Haralambieva IH, Vierkant RA, O'Byrne MM, Jacobson RM, Poland GA]
通讯作者:
Poland GA
共 16 条
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
-
批准号:8296557
-
项目类别:
-
资助金额:$1048.25万
-
财政年份:2011
-
负责人:Gregory A. Poland
-
依托单位:
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
-
批准号:8695082
-
项目类别:
-
资助金额:$508.17万
-
财政年份:2011
-
负责人:Gregory A. Poland
-
依托单位:
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
-
批准号:8509586
-
项目类别:
-
资助金额:$658.82万
-
财政年份:2011
-
负责人:Gregory A. Poland
-
依托单位:
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
-
批准号:8121282
-
项目类别:
-
资助金额:$645.1万
-
财政年份:2011
-
负责人:Gregory A. Poland
-
依托单位:
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
-
批准号:9118445
-
项目类别:
-
资助金额:$170.93万
-
财政年份:2011
-
负责人:Gregory A. Poland
-
依托单位:
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
-
批准号:7962443
-
项目类别:
-
资助金额:$349.69万
-
财政年份:2010
-
负责人:Gregory A. Poland
-
依托单位:
TRIAL OF RPA102 VACCINE IN HEALTHY ADULT VOLUNTEERS
-
批准号:7206213
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2005
-
负责人:Gregory A. Poland
-
依托单位:
ANTHRAX VACCINE ABSORBED (AVA): A HUMAN REACTOGENICITY AND IMMUNOGENICITY TRIAL
-
批准号:7206097
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2005
-
负责人:Gregory A. Poland
-
依托单位:
POPULATION GENETICS ANALYSIS PROGRAM: IMMUNITY TO VACCINES/INFECTIONS
-
批准号:7543659
-
项目类别:
-
资助金额:$89.51万
-
财政年份:2004
-
负责人:Gregory A. Poland
-
依托单位:--
Anthrax Vaccine Absorbed--Human Reactogenicity Trial
-
批准号:7042301
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2003
-
负责人:Gregory A. Poland
-
依托单位:
IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
-
批准号:6497390
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2001
-
负责人:Gregory A. Poland
-
依托单位:
IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
-
批准号:6628084
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2001
-
负责人:Gregory A. Poland
-
依托单位:
Immunogenetic Mechanisms of Vaccine Response
-
批准号:8435363
-
项目类别:
-
资助金额:$48.52万
-
财政年份:2001
-
负责人:Gregory A. Poland
-
依托单位:
Immunogenetic Mechanisms of Vaccine Response
-
批准号:7195743
-
项目类别:
-
资助金额:$57.62万
-
财政年份:2001
-
负责人:Gregory A. Poland
-
依托单位:
IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
-
批准号:6697431
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2001
-
负责人:Gregory A. Poland
-
依托单位:
Immunogenetic Mechanisms of Vaccine Response
-
批准号:8206515
-
项目类别:
-
资助金额:$51.19万
-
财政年份:2001
-
负责人:Gregory A. Poland
-
依托单位:
Immunogenetic Mechanisms of Vaccine Response
-
批准号:7578311
-
项目类别:
-
资助金额:$56.21万
-
财政年份:2001
-
负责人:Gregory A. Poland
-
依托单位:
Immunogenetic Mechanisms of Vaccine Response
-
批准号:7048017
-
项目类别:
-
资助金额:$44.4万
-
财政年份:2001
-
负责人:Gregory A. Poland
-
依托单位:
IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
-
批准号:6846274
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2001
-
负责人:Gregory A. Poland
-
依托单位:
IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
-
批准号:6254680
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2001
-
负责人:Gregory A. Poland
-
依托单位:
海外基金